Evidence map›Paper›PMID 26185426›Full record

ArticlePatient preference and adherence2015

Health-related quality of life and treatment satisfaction in patients with gout: results from a cross-sectional study in a managed care setting.

Puja P Khanna, Aki Shiozawa, Valery Walker, Tim Bancroft, Breanna Essoi, Kasem S Akhras, Dinesh Khanna

Open access · goldAbstract read
In one paragraph

Article in Patient preference and adherence, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Perceptions and practices of self-management among adult patients with gout at a primary care clinic: A qualitative study.Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Use of the Gout Impact Scale to Evaluate Quality of Life in Chinese Subjects with Gout: A Cross-Sectional Study.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Puja P KhannaDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Aki ShiozawaGlobal Outcome Research, Takeda Pharmaceuticals International, Inc., Deerfield, IL, USA.
Valery WalkerHealth Economics and Outcomes Research, Optum, Eden Prairie, MN, USA.
Tim BancroftHealth Economics and Outcomes Research, Optum, Eden Prairie, MN, USA.
Breanna EssoiHealth Economics and Outcomes Research, Optum, Eden Prairie, MN, USA.
Kasem S AkhrasNovartis Pharmacy Services AG, Dubai, United Arab Emirates.
Dinesh KhannaDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Optum (United States) · USUniversity of Michigan–Ann Arbor · USTakeda (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatient satisfaction with treatment directly impacts adherence to medication.

objectiveThe objective was to assess and compare treatment satisfaction with the Treatment Satisfaction Questionnaire for Medication (TSQM), gout-specific health-related quality of life (HRQoL) with the Gout Impact Scale (GIS), and generic HRQoL with the SF-12v2(®) Health Survey (SF-12) in patients with gout in a real-world practice setting.

methodsThis cross-sectional mail survey included gout patients enrolled in a large commercial health plan in the US. Patients were ≥18 years with self-reported gout diagnosis, who filled ≥1 prescription for febuxostat during April 26, 2012 to July 26, 2012 and were not taking any other urate-lowering therapies. The survey included the TSQM version II (TSQM vII, score 0-100, higher scores indicate better satisfaction), GIS (score 0-100, higher scores indicate worse condition), and SF-12 (physical component summary and mental component summary). Patients were stratified by self-report of currently experiencing a gout attack or not to assess the discriminant ability of the questionnaires.

resultsA total of 257 patients were included in the analysis (mean age, 54.9 years; 87% male). Patients with current gout attack (n=29, 11%) had worse scores than those without gout attack on most instrument scales. Mean differences between current attack and no current attack for the TSQM domains were: -20.6, effectiveness; -10.6, side effects; -12.1, global satisfaction (all P<0.05); and -6.1, convenience (NS). For the GIS, mean differences were: 30.5, gout overall concern; 14.6, gout medication side effects; 22.7, unmet gout treatment needs; 11.5, gout concern during attack (all P<0.05); and 7.9, well-being during attack (NS). Mean difference in SF-12 was -6.6 for physical component summary (P<0.05) and -2.9 for mental component summary (NS). Correlations between several TSQM and GIS scales were moderate.

conclusionThe TSQM and GIS were complementary in evaluating the impact of gout flare on treatment satisfaction and HRQoL. Correlations between the two instruments supported the relationship between treatment satisfaction and HRQoL.

Indexed as

febuxostatgoutGout Impact Scalegouty arthritisSF-12Treatment Satisfaction Questionnaire for Medicine

Identifiers

PMID26185426
PMCPMC4501348
OpenAlexW1845977127

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.